Curaleaf Q1 marijuana revenue climbs to $35.3 million

Curaleaf, a Massachusetts-based, vertically integrated cannabis company, reported first-quarter revenue of $35.3 million, up from $9.1 million for the same period in 2018.

Net loss for the company in the period totaled $10.8 million versus $3.4 million last year.

Curaleaf, which agreed to acquire Cura Partners in a nearly $1 billion deal earlier this month, trades on the Canadian Securities Exchange under the ticker symbol CURA.

More details on the results can be found here.

Get access to more in-depth market analysis, premium features on cannabis investing trends and monthly executive webcasts with an Investor Intelligence subscription.

One comment on “Curaleaf Q1 marijuana revenue climbs to $35.3 million
  1. Alex, a different dispensary sales agent who also lost their discount on

    Pretty cool that curaleaf decreased the employee discount on their products considering their profits have considerably improved this latest period!! What a great introduction this new industry is making on the Eastern side, following suit to the ever-evolving and greedy American business way. Forget the bottom-tier workers, who have a genuine interest and respect for marijuana and its medicinal values, the actual faces of the company. Remember and reward the corporate representatives for their lackluster knowledge of what a “hybrid” is thanks to their measly bachelorette degrees, as well as their associations with generic and overly-successful corporations like Pepsi. Congratulations, you are now and/or are on route to becoming the next Walmart of weed.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *